Ca2+-induced rebound potentiation of γ-aminobutyric acid-mediated currents requires activation of Ca2+/calmodulin-dependent kinase II

  1. Masanobu Kano*,,,
  2. Misao Kano§,
  3. Kohji Fukunaga, and
  4. Arthur Konnerth
  1. Departments of *Physiology, and §Clinical Pathology, Jichi Medical School, Minamikawachi-Machi, Tochigi 329-04, Japan; Laboratory for Neuronal Signal Transduction, Frontier Research Program, The Institute of Physical and Chemical Research, Wako-Shi, Saitama 351-01, Japan; Department of Pharmacology, Kumamoto University, Medical School, Kumamoto 860, Japan; and I Physiologisches Institut, Universität des Saarlandes, 66421 Homburg, Germany

Abstract

In cerebellar Purkinje neurons, γ-aminobutyric acid (GABA)-mediated inhibitory synaptic transmission undergoes a long-lasting “rebound potentiation” after the activation of excitatory climbing fiber inputs. Rebound potentiation is triggered by the climbing-fiber-induced transient elevation of intracellular Ca2+ concentration and is expressed as a long-lasting increase of postsynaptic GABAA receptor sensitivity. Herein we show that inhibitors of the Ca2+/calmodulin-dependent protein kinase II (CaM-KII) signal transduction pathway effectively block the induction of rebound potentiation. These inhibitors have no effect on the once established rebound potentiation, on voltage-gated Ca2+ channel currents, or on the basal inhibitory transmission itself. Futhermore, a protein phosphatase inhibitor and the intracellularly applied CaM-KII markedly enhanced GABA-mediated currents in Purkinje neurons. Our results demonstrate that CaM-KII activation and the following phosphorylation are key steps for rebound potentiation.

Footnotes

  • To whom reprint requests should be addressed at: Laboratory for Neuronal Signal Transduction, Frontier Research Program, The Institute of Physical and Chemical Research, Wako-shi, Saitama 351-01, Japan. e-mail: mkano{at}postman.riken.go.jp.

  • Richard F. Thompson, University of Southern California, Los Angeles, CA

  • Abbreviations: CaM-KII, Ca2+/calmodulin-dependent protein kinase II; GABA, γ-aminobutyric acid; GABAA receptor, type A GABA receptor; LTD, long-term depression; CBD, calmodulin-binding domain; PKA, cAMP-dependent protein kinase; PKC, protein kinase C; IPSC, inhibitory postsynaptic current; AMPA, α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid.

« Previous | Next Article »Table of Contents